Use access key #2 to skip to page content.
$43.56 1.11 (2.61%)
5/16/2008 4:01 PM

AstraZeneca plc (ADR) (AZN)

CAPS Rating:
****

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.

View All Commentary (AZN)

Recs

0

Avatar icanpickm (98.88) Submitted: 4/22/08 2:40 AM : Outperform Start Price: $40.63 AZN Score: 3.44

This seems like a no brainer, Crestor lowers the inflammation that causes heart attacks, even with patients with normal cholesterol. They halted their study early because the evidence was so strong. I am on it for cholesterol, but what a nice extra beny. The PE is 9 and the dividend is about 4.5%. I know big pharma is having their problems, but that has to be priced in. Long!

Report this Post Replies: 0 | Reply

Featured Broker Partners